Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141239 |
| CAS No | NA |
| Mol.F. | C13H11N3O4 |
| Mol.Wt. | 273.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141240 |
| CAS No | NA |
| Mol.F. | C12H13N3O2 |
| Mol.Wt. | 231.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141241 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141242 |
| CAS No | NA |
| Mol.F. | C8H7N3O2S |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141243 |
| CAS No | NA |
| Mol.F. | C17H18N4O3S |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141244 |
| CAS No | NA |
| Mol.F. | C18H22N4O4S |
| Mol.Wt. | 390.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141245 |
| CAS No | NA |
| Mol.F. | C16H16N4O3S |
| Mol.Wt. | 344.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141246 |
| CAS No | NA |
| Mol.F. | C17H18N4O4S |
| Mol.Wt. | 374.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141247 |
| CAS No | NA |
| Mol.F. | C17H18N4O6S |
| Mol.Wt. | 406.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141248 |
| CAS No | NA |
| Mol.F. | C17H18N4O4 |
| Mol.Wt. | 342.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141249 |
| CAS No | NA |
| Mol.F. | C15H15FN4O4 |
| Mol.Wt. | 334.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141250 |
| CAS No | NA |
| Mol.F. | C17H17ClN4O4 |
| Mol.Wt. | 376.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141251 |
| CAS No | NA |
| Mol.F. | C16H17FN4O2 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141252 |
| CAS No | NA |
| Mol.F. | C17H18N4O5 |
| Mol.Wt. | 358.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141253 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141254 |
| CAS No | NA |
| Mol.F. | C13H15BrN2O3 |
| Mol.Wt. | 327.2 |
| INV STATUS | CUSTOM SYNTHESIS |